Pros | ![]() Beats FD returns for both 3Y & 5Y duration. | |||
Cons | ![]() 5Y returns in the bottom 25% of the category. ![]() 3Y returns in the bottom 25% of the category. |
INDMoney rank | - | |||
Category,Subcateogry | Equity,Sector - Healthcare | |||
Fund Age | 6 Years | |||
Fund Size | 77 Cr | |||
Min Investment | SIP ₹200 Lumpsum ₹5000 | |||
Expense Ratio | 1.22% | |||
Exit Load | 1% | |||
Benchmark Index | S&P BSE Healthcare PR |
No of Holdings | 28 | |||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (9.93%) Piramal Pharma Ltd (5.37%) Torrent Pharmaceuticals Ltd (5.2%) Artemis Medicare Services Ltd Ordinary Shares (5.15%) Abbott India Ltd (4.73%) | |||
No of Sectors | 2 | |||
Top 3 Sectors | Health (93.24%) Basic Materials (6.76%) | |||
Equity % | 97.63% | |||
Debt % | - | |||
P/E | 40.65 | |||
P/B | 5.97 | |||
Credit Quality | - | |||
Modified Duration | - | |||
YTM | - |
1-Month Return | 8.82% | |||
3-Month Return | -5.86% | |||
6-Month Return | -4.31% | |||
1-Year Return | 20.73% | |||
3-Year Return | 17.76% | |||
5-Year Return | 25.65% |
Sharpe | 0.61 | |||
Alpha | -1.54 | |||
Beta | 0.92 | |||
Standard Deviation | 15.99 | |||
Information Ratio | -0.68 |
Description | LIC MF Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | |||
Managers | Karan Doshi |